In Reply

Author:

Coomes Eric A.1,Al-Shamsi Humaid O.234,Meyers Brandon M.5,Alhazzani Waleed6,Alhuraiji Ahmad7,Chemaly Roy F.8,Almuhanna Meshari9,Wolff Robert A.10,Ibrahim Nuhad K.11,Chua Melvin L.K.121314,Hotte Sebastien J.5,Elfiki Tarek1516,Curigliano Giuseppe1718,Eng Cathy19,Grothey Axel20,Xie Conghua14

Affiliation:

1. Division of Infectious Disease, Department of Medicine, University of Toronto, Toronto, Canada

2. Medical Oncology Department, Alzahra Hospital Dubai, Dubai, United Arab Emirates

3. Department of Medicine, University of Sharjah, Sharjah, United Arab Emirates

4. Emirates Oncology Society, Dubai, United Arab Emirates

5. Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Canada

6. Department of Health Research Methods, Evidence, and Impact and Department of Medicine, McMaster University, Hamilton, Canada

7. Department of Hematology, Kuwait Cancer Control Center, Kuwait City, Kuwait

8. Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

9. Min-Sheng General Hospital, Taoyuan District, Taoyuan City, Taiwan

10. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

11. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

12. Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore, Singapore

13. Oncology Academic Program, Duke-NUS Medical School, Singapore

14. Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China

15. Windsor Regional Cancer Center, Windsor, Canada

16. Department of Oncology, Schulich School of Medicine, University of Western Ontario, London, Canada

17. Department of Oncology and Hemato-Oncology and Division of Early Drug Development for Innovative Therapy, University of Milan, Milan, Italy

18. European Institute of Oncology, IRCCS, Milan, Italy

19. Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA

20. West Cancer Center, University of Tennessee, Memphis, Tennessee, USA

Abstract

This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID-19 pandemic, in response to the letter by Boutayeb et al.

Funder

Roche

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3